This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schiller, N L Articles by Joiner, K A Search for Related Content PubMed PubMed Citation Articles by Schiller, N L Articles by Joiner, K A

Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

ABSTRACT

The interaction of complement with the following two strains of Pseudomonas aeruginosa was examined: 144M, a mucoid, serum-sensitive strain bearing short lipopolysaccharide O chains, and 144M-SR, a mucoid, serum-resistant strain bearing long lipopolysaccharide O chains isolated by repeated passage of 144M in increasing concentrations of pooled normal human serum (PNHS). While significant killing of 144M occurred in 5 to 40% PNHS, no killing of 144M-SR was observed. Both strains activated complement, especially 144M-SR which consumed 88.7, 96.4, and 100% of the available complement 3 (C3), C5, and C9, respectively, in 10% PNHS during a 60-min incubation at 37 degrees C. Although it activated more C3 than did 144M (54.9% consumption), 144M-SR bound only half as much C3 as 144M. Similarly, although 144M-SR activated more C9 than did 144M (50.0% consumption in 60 min), there was considerably less C9 attached to 144M-SR (2,990 molecules of C9 per bacterium) than to 144M (13,700 molecules per bacterium) after 60 min of incubation. Furthermore, only 162 molecules of the C9 bound to 144M-SR remained bound after treatment with 0.1% trypsin, while 5,692 molecules of the C9 bound to 144M remained bound under similar conditions. These results show that the serum resistance of 144M-SR does not represent a failure to activate complement efficiently, but instead reflects failure of the assembled terminal complement complex C5b-9 to insert stably into the outer membrane of this strain.

This article has been cited by other articles:

• Kunert, A., Losse, J., Gruszin, C., Huhn, M., Kaendler, K., Mikkat, S., Volke, D., Hoffmann, R., Jokiranta, T. S., Seeberger, H., Moellmann, U., Hellwage, J., Zipfel, P. F. (2007). Immune Evasion of the Human Pathogen Pseudomonas aeruginosa: Elongation Factor Tuf Is a Factor H and Plasminogen Binding Protein. J. Immunol. 179: 2979-2988 [Abstract] [Full Text]  
• Ragupathi, G., Liu, N. X., Musselli, C., Powell, S., Lloyd, K., Livingston, P. O. (2005). Antibodies against Tumor Cell Glycolipids and Proteins, but Not Mucins, Mediate Complement-Dependent Cytotoxicity. J. Immunol. 174: 5706-5712 [Abstract] [Full Text]  
• Younger, J. G., Shankar-Sinha, S., Mickiewicz, M., Brinkman, A. S., Valencia, G. A., Sarma, J. V., Younkin, E. M., Standiford, T. J., Zetoune, F. S., Ward, P. A. (2003). Murine Complement Interactions with Pseudomonas aeruginosa and Their Consequences During Pneumonia. Am. J. Respir. Cell Mol. Bio. 29: 432-438 [Abstract] [Full Text]  
• Sar, B., Oishi, K., Wada, A., Hirayama, T., Matsushima, K., Nagatake, T. (1999). Nitrite Reductase from Pseudomonas aeruginosa Released by Antimicrobial Agents and Complement Induces Interleukin-8 Production in Bronchial Epithelial Cells. Antimicrob. Agents Chemother. 43: 794-801 [Abstract] [Full Text]